Multi-dosage tablet array

Inventors

HELSPER, Freek • TESINK, Anthonie Sebastiaan

Assignees

Alfasan Nederland BV

Abstract

Described is a multi-dosage array of tablets comprising one or more active substances, the tablets being coated and void of tablet portioning means so as to avoid contact of the tablet constituents upon handling by a user for the provision of a plurality of different dosages of the one or more active substances to a plurality of patients of different weight who are in need of the said one or more active substances, the dosage being dependent on the weight of the respective patient, the array of tablets comprising three or more tablet groups, each tablet group consisting of identical tablets having unique identification means and a unique dosage of the one or more active substances, the said tablets differing from tablets of another group of the array in at least the dosage of the said two or more active substances and in the identification means. Further described are a multi-dosage tablet array system, a medicament dosage comprising a plurality of the tablets of the multi-dosage array of tablets, a dosage comprising a plurality of the tablets of the multi-dosage tablet array, a method of providing a dosage of one or more active substances tailored to the body weight of a patient and a method of providing a tailored dosage of one or more active substances to the body weight of a patient.

Core Innovation

The invention relates to a multi-dosage tablet array system for treatment of an intended animal patient, where the tablets are coated and void of tablet portioning means. The system comprises a plurality of multi-dosage arrays of tablets, with each multi-dosage array containing three or more tablet groups. All tablets in a single multi-dosage array have the same active substances, while different multi-dosage arrays have differing active substances.

Within each multi-dosage array, each tablet group consists of a plurality of identical tablets that include one or more veterinary active substances. The tablets of a tablet group have a dosage of the one or more active substances tailored for a predetermined body weight, and the tablet group includes an identifier that identifies the corresponding dosage. Tablets in the same tablet group that have the same dosage also have the same identifier, while tablets of different tablet groups differ in dosage and in the identifier, with the dosage tailored to a different predetermined body weight.

The three or more tablet groups within each multi-dosage array include tablet groups with dosages characteristic of that array, tailored to the same predetermined body weights. The same-body-weight tablets across different tablet groups have the same identifier, enabling consistent identification for a target body weight. A multi-array system also permits combination of different active substances while preserving shared identification for the same target body weight.

Claims Coverage

The coverage is anchored by one independent claim directed to a multi-dosage tablet array system for veterinary treatment. The claim set includes five inventive features centered on coated tablets without tablet portioning means, multiple tablet groups with identical tablets per group, dosage tailored to predetermined body weights, and a dosage-linked identifier for corresponding tablet groups, with dependent claims further refining dosage relationships and identifier presentation.

Overall, the claim coverage protects a veterinary multi-dosage coated tablet array system without tablet portioning means, organized into three or more tablet groups of identical tablets. Each group provides a dosage tailored to a predetermined body weight and is paired with an identifier so that matching dosages share the same identifier across groups and across multi-dosage arrays.

Stated Advantages

Documented Applications